EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) purchased 103.7% of their position (1.97M shares) of AIM IMMUNOTECH INC. on the open market
Open‑market purchase worth $50.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/23/2025ACC: 0001641172-25-005861
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+1.97M
Net shares
Net buyer
$50.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.97M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.97M
Price / share
$0.03
Trade value
$50K
% of position
103.7%
4/11/2025
1.90M→3.87M
Total
Net shares
+1.97M
Net value
$50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/11/2025 | P · Purchase | +1.97M | $0.03 | $50K | 103.7% | 1.90M | 3.87M |
| Total | +1.97M | $50K | ||||||
Derivative Transactions0
No derivative transactions reported